SCHEMBL817079

SCHEMBL817079

CCC(=O)NS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL564159 0.75
SCHEMBL389017 0.72
SCHEMBL1169137 0.72 ALDH1A1 (0.50)
SCHEMBL4969215 0.72 PHF8 (0.38)
SCHEMBL10988952 0.71
SCHEMBL18469054 0.71
SCHEMBL23816237 0.69
SCHEMBL213654 0.69
SCHEMBL9329 0.69
SCHEMBL27418841 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5210266-A Analgesic enkephalinase inhibitors DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1993-05-11 US claimed
US-5179125-A Analgesics DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1993-01-12 US claimed
EP-0318859-A2 N-substituted mercaptopropanamide derivatives Dainippon Pharmaceutical Co., Ltd. (JP) 1989-06-07 EP claimed
US-20260083724-A1 COMPOUNDS TARGETING PAX3::FOXO1 FUSION PROTEIN GEORGETOWN UNIVERSITY (US) 2026-03-26 US disclosed
US-20250313835-A1 MICELLAR NANOPARTICLES AND USES THEREOF BIORCHESTRA CO., LTD. (KR) 2025-10-09 US disclosed
EP-4603589-A2 MICELLAR NANOPARTICLES AND USES THEREOF Biorchestra Co., Ltd. (KR) 2025-08-20 EP disclosed
WO-2025149946-A1 MICELLAR NANOPARTICLES AND USES THEREOF BIORCHESTRA CO., LTD. (KR) 2025-07-17 WO disclosed
WO-2025132323-A1 COMPOSITIONS COMPRISING A SUNSCREEN ACTIVE AGENT DSM-FIRMENICH AG (CH) 2025-06-26 WO disclosed
EP-3990028-B1 MICELLAR NANOPARTICLES AND USES THEREOF BIORCHESTRA CO LTD (KR) 2025-06-04 EP disclosed
EP-4551193-A1 MICELLAR NANOPARTICLES AND USES THEREOF Biorchestra Co., Ltd. (KR) 2025-05-14 EP disclosed
US-20240294908-A1 USE OF MIRNA-485 INHIBITORS FOR TREATING DISEASES OR DISORDERS ASSOCIATED WITH ABNORMAL NLRP3 EXPRESSION BIORCHESTRA CO., LTD. (KR) 2024-09-05 US disclosed
US-5179125-A Analgesics DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1993-01-12 US disclosed
US-5179125-A Analgesics DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1993-01-12 US disclosed
EP-0318859-A3 N-SUBSTITUTED MERCAPTOPROPANAMIDE DERIVATIVES Dainippon Pharmaceutical Co., Ltd. (JP) 1990-08-16 EP disclosed
EP-0318859-A2 N-substituted mercaptopropanamide derivatives Dainippon Pharmaceutical Co., Ltd. (JP) 1989-06-07 EP disclosed
EP-0318859-A2 N-substituted mercaptopropanamide derivatives Dainippon Pharmaceutical Co., Ltd. (JP) 1989-06-07 EP disclosed
EP-0318859-A2 N-substituted mercaptopropanamide derivatives Dainippon Pharmaceutical Co., Ltd. (JP) 1989-06-07 EP disclosed
EP-0159254-B1 DERIVATIVES OF OMEGA-MERCAPTOPROPANAMIDE AND THEIR SALTS, THEIR PREPARATION, THEIR USE AS MEDICINES AND COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1987-10-07 EP disclosed
US-4518597-A THROMBOSIS, ARTERIOSCLEROSIS, ANTITUMOR, ANTICOAGULANTS DR. KARL THOMAE GMBH (DE) 1985-05-21 US disclosed
US-4283407-A ANTIHYPERTENSIVE AGENTS SCIENCE UNION ET CIE (FR) 1981-08-11 US disclosed